Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Cash (2016 - 2025)

Historic Change in Cash for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $2.9 million.

  • OptimizeRx's Change in Cash rose 15141.39% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 4530.95%. This contributed to the annual value of -$472000.0 for FY2024, which is 8916.69% up from last year.
  • As of Q3 2025, OptimizeRx's Change in Cash stood at $2.9 million, which was up 15141.39% from $12000.0 recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Change in Cash ranged from a high of $71.8 million in Q1 2021 and a low of -$46.1 million during Q3 2022
  • For the 5-year period, OptimizeRx's Change in Cash averaged around $473784.7, with its median value being $115000.0 (2023).
  • Per our database at Business Quant, OptimizeRx's Change in Cash soared by 207006.82% in 2021 and then crashed by 606858.1% in 2022.
  • Quarter analysis of 5 years shows OptimizeRx's Change in Cash stood at -$374808.0 in 2021, then crashed by 6068.58% to -$23.1 million in 2022, then surged by 117.0% to $3.9 million in 2023, then tumbled by 169.87% to -$2.7 million in 2024, then surged by 206.85% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $12000.0 for Q2 2025, and $3.2 million during Q1 2025.